|
2024
|
Invention
|
Radiopharmaceutical complexes and combinations. The present invention relates to tissue-targeting... |
|
|
Invention
|
Anti-gpc3 antibodies and radioconjugates thereof. The present disclosure relates to novel antibod... |
|
2023
|
Invention
|
Radiopharmaceutical complexes targeting prostate-specific membrane antigen and its combinations |
|
|
Invention
|
Radiopharmaceutical complexes targeting prostate-specific membrane antigen and its combinations. ... |
|
2022
|
Invention
|
Multimeric chelator compounds for use in targeted radiotherapy.
The present invention covers com... |
|
|
Invention
|
Multimeric chelator compounds for use in targeted radiotherapy. The present invention covers comp... |
|
|
Invention
|
Radio-pharmaceutical complexes.
The invention provides a method for the formation of a tissue-ta... |
|
|
Invention
|
Lrrc15 antibodies and conjugates thereof.
The present invention relates to conjugates comprising... |
|
|
Invention
|
Lrrc15 antibodies and conjugates thereof. The present invention relates to conjugates comprising ... |
|
2021
|
Invention
|
Pharmaceutical preparation.
The present invention provides a method for generating purified solu... |
|
2020
|
Invention
|
Isotope preparation method.
The present invention provides a method for the generation of 223Ra ... |
|
|
Invention
|
Targeted radiopharmaceuticals for the diagnosis and treatment of prostate cancer.
A compound of ... |
|
|
Invention
|
Targeted radiopharmaceuticals for the diagnosis and treatment of prostate cancer. A compound of g... |
|
|
Invention
|
Purification method.
The invention provides a method for the purification of complexed 227Th fro... |
|
|
Invention
|
Isotope preparation method. 227Th solution.
Purified thorium-227 of pharmaceutical p... |
|
|
Invention
|
Combination of pd-1/pd-l1 inhibitors and targeted thorium conjugates.
The present invention rela... |
|
|
Invention
|
Combination of ar antagonists and targeted thorium conjugates.
The present invention covers comb... |
|
|
Invention
|
Combination of pd-1/pd-l1 inhibitors and targeted thorium conjugates. The present invention relat... |
|
|
Invention
|
Combination of ar antagonists and targeted thorium conjugates. The present invention covers combi... |
|
2019
|
Invention
|
Combination of pi3k-inhibitors and targeted thorium conjugates. The present invention relates to ... |
|
2018
|
Invention
|
Combination therapy comprising a radiopharmaceutical and a dna-repair inhibitor.
The present inv... |
|
|
Invention
|
Combination therapy comprising a radiopharmaceutical and a dna-repair inhibitor. The present inve... |
|
2017
|
Invention
|
Method for the quantification of 227ac in 223ra compositions.
A method for the quantification of... |
|
|
Invention
|
Alpha-emitting complexes. The present invention provides a tissue-targeting complex comprising a ... |
|
|
Invention
|
Radio-pharmaceutical complexes. The invention provides a method for the formation of a tissue-tar... |
|
2016
|
Invention
|
Purification method. The invention provides a method for the purification of complexed 227Th from... |
|
|
Invention
|
Isotope preparation method. 227Th solution, a corresponding pharmaceutical formulation and method... |
|
|
Invention
|
Isotope preparation method.
The present invention comprises a method for the generation of 227Th... |
|
|
Invention
|
Isotope purification method. The invention provides a method for the purification of 227 Th from ... |
|
|
Invention
|
Isotope preparation method. The present invention comprises a method for the generation of 227 Th... |
|
|
Invention
|
Isotope preparation method. The present invention provides a method for the purification of 227Th... |
|
2014
|
Invention
|
Method for the quantification of 227ac in 223ra compositions. 227Ac absorbed onto the resin in co... |
